Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Zoetis Inc. ZTS
$182.78
-$2.31 (-1.26%)
На 18:00, 12 мая 2023
+30.90%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
85100235360.00000000
-
week52high
187.82
-
week52low
124.15
-
Revenue
8080000000
-
P/E TTM
41
-
Beta
0.76262900
-
EPS
4.42000000
-
Last Dividend
1.50000000
-
Next Earnings Date
04 мая 2023 г. в 12:30
Описание компании
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Buy | Buy | 21 июл 2022 г. |
| Piper Sandler | Overweight | 12 июл 2022 г. | |
| Stifel | Buy | Buy | 24 июн 2022 г. |
| Goldman Sachs | Buy | Buy | 19 мая 2022 г. |
| Citigroup | Neutral | Neutral | 09 мар 2022 г. |
| JP Morgan | Overweight | Overweight | 17 окт 2022 г. |
| Goldman Sachs | Buy | Buy | 04 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Ferran Astorga Jeannette | A | 464 | 81 | 13 янв 2023 г. |
| Lagano Roxanne | A | 24783 | 130 | 13 янв 2023 г. |
| PECK KRISTIN C | A | 43482 | 271 | 13 янв 2023 г. |
| Joseph Wetteny | A | 953 | 158 | 13 янв 2023 г. |
| Driscoll Rimma | A | 3687 | 95 | 13 янв 2023 г. |
| Mamilli Wafaa | A | 5670 | 142 | 13 янв 2023 г. |
| David Glenn | A | 24795 | 164 | 13 янв 2023 г. |
| Chen Heidi C. | A | 7833 | 139 | 13 янв 2023 г. |
| Polzer Robert J | A | 7419 | 118 | 13 янв 2023 г. |
| David Glenn | A | 24631 | 209 | 07 окт 2022 г. |
Новостная лента
Zoetis' Dividend Growth: Small Yield, Big Returns
Seeking Alpha
10 мая 2023 г. в 11:44
The article discusses Zoetis, a low-yielding dividend stock with high dividend growth potential. Zoetis is the world's leading producer of medicine and vaccinations for pets and livestock, with a global footprint of over 100 markets and more than 70 years of experience.
Zoetis (ZTS) Q1 Earnings Top Estimates
Zacks Investment Research
04 мая 2023 г. в 09:55
Zoetis (ZTS) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.32 per share a year ago.
Zoetis Tumbles As Spot's Drugmaker Reports Mixed Earnings, Though Keeps Outlook
Investors Business Daily
04 мая 2023 г. в 09:27
Animal health behemoth Zoetis reported a mixed first quarter but kept its full-year outlook. Still, ZTS stock tumbled early Thursday.
Zoetis Stock Falls Amid Mixed Earnings Report
Barrons
04 мая 2023 г. в 07:35
The animal health provider maintained its guidance for full year 2023 after first quarter earnings beat expectations.
My Top 15 High-Growth Dividend Stocks For May 2023
Seeking Alpha
01 мая 2023 г. в 12:30
I present my top 15 high-growth dividend stocks to consider during the month of May. The watchlist posted a gain of 0.41% in April, trailing both VIG and SPY.